FDA orders doctors to stop prescribing drugs linked to birth defects

Doctors in Taiwan have been instructed to stop prescribing valproate-containing medicines, which are primarily used to treat epilepsy, bipolar disorder and prevent migraines, to pregnant women in the wake of growing evidence that links valproate to birth defects, the Food and Drug Administration (FDA) announced Monday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)